AIMS: To review the recent literature relating to the role of self-monitoring of blood glucose (SMBG) and glycemic control. METHODS: Medline and EMBASE databases were searched between 1996 and June 2008 using terms that included diabetes mellitus, self-care, and blood glucose self monitoring. Both experimental and nonexperimental studies with HbA(1c) as an outcome measure were included. A meta-analysis was performed on randomized controlled trials (RCTs) in type 2 diabetes which met the inclusion criteria. RESULTS: From 1102 relevant papers, 34 original containing 38 separate studies were identified as being published between 2000 and June 2008. There were 23 studies of type 2 diabetes and, of these, 13 were nonexperimental and 10 experimental, including six RCTs. The results of five of these RCTs in non-insulin-treated type 2 diabetic patients were combined in a meta-analysis with two earlier RCTs which yielded a significant pooled SMBG-related decrease in HbA(1c) of -0.22 (95% CI -0.34% to -0.11%). CONCLUSIONS: The present meta-analysis showed an SMBG-related HbA(1c) reduction in non-insulin-treated type 2 diabetes patients that was similar to that in previous systematic reviews but in a substantially larger patient sample. This finding is consistent with most observational studies of similarly treated patients.
AIMS: To review the recent literature relating to the role of self-monitoring of blood glucose (SMBG) and glycemic control. METHODS: Medline and EMBASE databases were searched between 1996 and June 2008 using terms that included diabetes mellitus, self-care, and blood glucose self monitoring. Both experimental and nonexperimental studies with HbA(1c) as an outcome measure were included. A meta-analysis was performed on randomized controlled trials (RCTs) in type 2 diabetes which met the inclusion criteria. RESULTS: From 1102 relevant papers, 34 original containing 38 separate studies were identified as being published between 2000 and June 2008. There were 23 studies of type 2 diabetes and, of these, 13 were nonexperimental and 10 experimental, including six RCTs. The results of five of these RCTs in non-insulin-treated type 2 diabeticpatients were combined in a meta-analysis with two earlier RCTs which yielded a significant pooled SMBG-related decrease in HbA(1c) of -0.22 (95% CI -0.34% to -0.11%). CONCLUSIONS: The present meta-analysis showed an SMBG-related HbA(1c) reduction in non-insulin-treated type 2 diabetespatients that was similar to that in previous systematic reviews but in a substantially larger patient sample. This finding is consistent with most observational studies of similarly treated patients.
Authors: Mary Ann Sevick; Mary Korytkowski; Roslyn A Stone; Beth Piraino; Dianxu Ren; Susan Sereika; Yuanyuan Wang; Ann Steenkiste; Lora E Burke Journal: J Acad Nutr Diet Date: 2012-08 Impact factor: 4.910
Authors: David C Klonoff; Lawrence Blonde; George Cembrowski; Antonio Roberto Chacra; Guillaume Charpentier; Stephen Colagiuri; George Dailey; Robert A Gabbay; Lutz Heinemann; David Kerr; Antonio Nicolucci; William Polonsky; Oliver Schnell; Robert Vigersky; Jean-François Yale Journal: J Diabetes Sci Technol Date: 2011-11-01
Authors: Lisa M McAndrew; Carol R Horowitz; Kristie J Lancaster; Karen S Quigley; Leonard M Pogach; Pablo A Mora; Howard Leventhal Journal: J Diabetes Date: 2011-06 Impact factor: 4.006
Authors: Andreas Schmitt; Annika Gahr; Norbert Hermanns; Bernhard Kulzer; Jörg Huber; Thomas Haak Journal: Health Qual Life Outcomes Date: 2013-08-13 Impact factor: 3.186